Smith & Nephew completes acquisition of surgical robotics business
Medical tech business Smith & Nephew has completed the acquisition of surgical robotics business Blue Belt Technologies.
FTSE 100
8,030.33
17:15 13/11/24
FTSE 350
4,434.70
17:14 13/11/24
FTSE All-Share
4,392.88
16:44 13/11/24
Health Care Equipment & Services
10,240.67
17:14 13/11/24
Smith & Nephew
951.40p
17:00 13/11/24
The FTSE 100 company announced the completion of the deal on Monday, which was originally announced in October last year.
It said the deal, which is valued at $275m (£186.8m), will secure a leading position in the fast-growing area of orthopaedic robotics-assisted surgery.
The group also highlighted that it intends to expand Blue Belt Technologies' Navio surgical platform, from robotics-assistance in unicondylar or partial knee replacement surgery into a wider range of functions including total knee implants.
In October, the company said it was “a compelling strategic move” which reinforces the company’s “distinctive orthopaedic reconstruction strategy”.